INmune Bio Inc.
INMB
$1.21
-$0.01-0.82%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.71% | -10.76% | -16.90% | 72.59% | -7.58% |
| Total Receivables | -83.04% | 84.29% | 14.34% | 52.19% | 0.50% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.64% | 26.06% | -6.53% | 143.96% | -37.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -23.64% | -2.55% | -14.89% | 71.92% | -7.51% |
|
|
|||||
| Total Current Assets | -23.64% | -2.55% | -14.89% | 71.92% | -7.51% |
| Net Property, Plant & Equipment | 23.76% | -3.76% | 79.81% | 288.49% | -9.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.79% | -20.24% | 30.88% | 1,063.27% | -37.97% |
| Total Assets | -20.19% | -3.02% | -11.48% | -0.31% | -4.45% |
|
|
|||||
| Total Accounts Payable | -40.02% | 12.99% | -10.38% | 6.57% | 10.08% |
| Total Accrued Expenses | 0.00% | 0.00% | -86.41% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.00% | 36.32% | 107.73% | 50.68% | 4.29% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -12.35% | 12.77% |
| Total Other Current Liabilities | -- | -- | -- | -12.35% | 12.77% |
| Total Current Liabilities | -35.98% | 14.39% | -14.31% | 8.31% | 9.78% |
|
|
|||||
| Total Current Liabilities | -35.98% | 14.39% | -14.31% | 8.31% | 9.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 96.11% | -34.03% | 169.70% | 14.93% | -17.62% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -29.83% | 10.61% | -9.49% | 8.48% | 8.88% |
|
|
|||||
| Common Stock & APIC | 0.64% | 1.47% | 1.31% | 11.72% | 3.75% |
| Retained Earnings | -2.59% | -2.58% | -3.28% | -14.15% | -5.97% |
| Treasury Stock & Other | 1.36% | 3.53% | -0.13% | -25.08% | -6.09% |
| Total Common Equity | -16.58% | -7.31% | -12.09% | -2.72% | -7.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.58% | -7.31% | -12.09% | -2.72% | -7.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.58% | -7.31% | -12.09% | -2.72% | -7.55% |
|
|
|||||